NCT03616886: Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 129 taking part
- Started
- 28 Dec 2018
- Primary completion
- 21 May 2021
- Arms
- Phase I and Phase II Arm A
- Results
- None posted
- 6 Aug 2018: Trial registered
- 28 Dec 2018: Trial started